Shabnam Movassaghi

Shabnam Movassaghi

Auto-generated profile, based on publicly available information

Shabnam Movassaghi

Islamic Azad University, Faculty of Medicine, Tehran Medical Sciences, Department of Anatomical Sciences & Cognitive Neuroscience, Tehran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2011 in Stroke Research and Treatment
Verified
Journal Article
Open access
PDF file
ZSZahra-Nadia Sharifi
Zahra-Nadia Sharifi
FAFarid Abolhassani
Farid Abolhassani
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
SMShabnam Movassaghi
Shabnam Movassaghi
NRNasrin Rahimian
Nasrin Rahimian
Gholamreza HassanzadehGholamreza Hassanzadeh
Gholamreza Hassanzadeh
Transient global cerebral ischemia causes loss of pyramidal cells in CA1 region of hippocampus. In this study, we investigated the neurotrophic effect of the immunosuppressant agent FK506 in rat after global cerebral ischemia. Both common carotid arteries were occluded for 20 minutes followed by reperfusion. In experimental group 1, FK506 (6 mg/kg) was given as a single dose exactly at the time of reperfusion. In the second group, FK506 was administered at the beginning of reperfusion, followed by its administration intraperitoneally (IP) 6, 24, 48, and 72 hours after reperfusion. FK506 failed to show neurotrophic effects on CA1 region when applied as a single dose of 6 mg/kg. The cell number and size of the CA1 pyramidal cells were increased, also the number of cell death decreased in this region when FK506 was administrated 48 h after reperfusion. This work supports the possible use of FK506 in treatment of ischemic brain damage.

1 September 2012
Verified
Journal Article
Open access
SMShabnam Movassaghi
Shabnam Movassaghi
ZSZahra Nadia Sharifi
Zahra Nadia Sharifi
MSMansooreh Soleimani
Mansooreh Soleimani
MJMohammad Taghi Joghataii
Mohammad Taghi Joghataii
MHMehrdad Hashemi
Mehrdad Hashemi
MMmehdi mehdizadeh
mehdi mehdizadeh
The brief interruption of cerebral blood flow causes permanent brain damage and behavioral dysfunction. The hippocampus is highly vulnerable to ischemic insults, particularly the CA1 pyramidal cell layer. There is no effective pharmacological strategy for improving brain tissue damage induced by cerebral ischemia. Previous studies reported that pentoxifylline (PTX) has a neuroprotective effect on brain trauma. The possible neuroprotector effects of PTX on behavioral deficit were studied in male Wistar rats subjected to a model of transient global brain ischemia. Animals (n= 32) were assigned to control, sham-operated, vehicle, and PTX- treated (200 mg/kg IP) groups. PTX administered at 1hr before and 3 hr after ischemia. Global cerebral ischemia was induced by bilateral common carotid artery occlusion, followed by reperfusion. Morris Water maze testing revealed that PTX administration in cerebral ischemia significantly improved hippocampal-dependent memory and cognitive spatial abilities after reperfusion as compared to sham-operated and vehicle-treated animals. After the behavioral test, the rats were sacrificed and brain sections were stained with Nissl staining. There were no significant differences between number of pyramidal cells in both control and PTX groups. Our study demonstrated that pentoxifylline had a protective effect on rats with transient global ischemia and could reduce cognitive impairment.

1 August 2013
Verified
Journal Article
Open access
SMShabnam Movassaghi
Shabnam Movassaghi
ZSZahra Nadia Sharifi
Zahra Nadia Sharifi
FMFarzaneh Mohammadzadeh
Farzaneh Mohammadzadeh
MSMansooreh Soleimani
Mansooreh Soleimani
3,4-Methylenedioxymethamphetamine (MDMA) is one of the most popular drugs of abuse in the world with hallucinogenic properties that has been shown to induce apoptosis in liver cells. The present study aimed to investigate the effects of pentoxifylline (PTX) on liver damage induced by acute administration of MDMA in Wistar rat. Animals were administered with saline or MDMA (7.5 mg/kg, IP) 3 times with 2 hr intervals. PTX (200 mg kg, IP), was administered simultaneously with last injection of MDMA in experimental group. The concomitant administration of pentoxifylline and MDMA decreased liver injury including apoptosis, fibrosis and hepatocytes damages. Our results showed for the first time that PTX treatment diminishes the extent of apoptosis and fibrosis caused by MDMA in rat liver.

1 February 2015
Verified
Journal Article
Open access
FDFataneh Hashem Dabaghian
Fataneh Hashem Dabaghian
MHMehrdad Hashemi
Mehrdad Hashemi
MEMaliheh Entezari
Maliheh Entezari
SMShabnam Movassaghi
Shabnam Movassaghi
SGSeyed Ashrafadin Goushegir
Seyed Ashrafadin Goushegir
ZSZahra Nadia Sharifi
Zahra Nadia Sharifi
Global cerebral ischemia-reperfusion injury causes loss of pyramidal cells in CA1 region of hippocampus. In this study, we investigated the possible neuroprotective effects of the ethanol extract of Cyperus rotundus (EECR) on a model of global transient ischemia in rat, by evaluating the pathophysiology of the hippocampal tissue and spatial memory. Treatment group (EECR, 100 mg/kg/day) was gavaged from 4 days before, to 3 days after ischemia. Morris water maze test was performed 1 week after ischemia for 4 days. Brain tissue was prepared for Nissl staining. Our data showed no statistical difference between the treatment and ischemia groups in water maze task. So, treatment of ischemia with EECR cannot improve spatial learning and memory. On the contrary EECR ameliorated the CA1 pyramidal cell loss due to transient global ischemia/reperfusion injury. These results suggest that EECR cannot reduce the ischemia-induced, cognitive impairments seen after transient, global cerebral ischemia but can prevent pyramidal cell loss in CA1 region of hippocampus.

17 May 2021 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
SYSoheila Yadollah-Damavandi
Soheila Yadollah-Damavandi
ZSZahra Nadia Sharifi
Zahra Nadia Sharifi
HAHamid Zaferani Arani
Hamid Zaferani Arani
EJEhsan Jangholi
Ehsan Jangholi
AKAliasghar Karimi
Aliasghar Karimi
SMShabnam Movassaghi
Shabnam Movassaghi
Background: Atorvastatin is a member of statins, which has shown positive vascular effects, anti-oxidant, anti-platelet, and anti-apoptotic properties. Objective: In this study, we hypothesized that atorvastatin could prevent the neurons lost in the hippocampal dentate gyrus region after transient global Ischemia/Reperfusion (I/R) through its anti- oxidant and anti-apoptotic activities. Method: Twenty-four male Wistar rats, 12-13 weeks old and weighing 250–300 g, were divided randomly into four groups: control, I/R, vehicle (I/R treated with NaCl) and experiment (I/R treated with atorvastatin, 10 mg/kg); rats were sacrificed 96 hours after I/R. Quantitative expression of genes (caspase 8, p53, bax, bcl2, cytochrome c) was studied. The MDA level, SOD, CAT, and GPx activities were measured with biochemical tests. To detect apoptotic cells, TUNEL and Nissl staining were performed. Mitochondria were prepared from the hippocampus rats and used for the quantification of mitochondrial ROS, ATP level, GSH content, membrane potential, cytochrome c release, and determination of mitochondrial swelling. Results: Atorvastatin attenuated the overexpression of bax, cytochrome C, p53, and caspase8 mRNAs and induced expression of bcl-2 mRNA (P<0.001). Atorvastatin treatment increased anti-oxidant enzyme levels (P<0.01). Treatment with atorvastatin reduced the number of TUNEL-positive cells. It could decrease the cytochrome c release (P<0.01), inhibit the decrease of MMP (P<0.001) and increase the ATP level (P<0.001) in hippocampal mitochondria compared with the I/R group. Conclusion: Atorvastatin treatment in I/R rats decreases oxidative stress, production of ROS, apoptosis rate in neuronal cells, and improves the mitochondrial function. Hence, atorvastatin has a proper neuronal protective effect against the I/R injury in the brain.

18 May 2013 in Archives of Neuroscience
Verified
Journal Article
Open access
PDF file
ZSZahra Nadia Sharifi
Zahra Nadia Sharifi
FAFarid Abolhassani
Farid Abolhassani
GHGholamreza Hassanzadeh
Gholamreza Hassanzadeh
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
SMShabnam Movassaghi
Shabnam Movassaghi
Background: Behavioral studies on animals demonstrated that hippocampal damage could produce learning and memory impairments particularly spatial learning. It has been shown that ischemic damage restricted to only 50% of the CA1 cells of the hippocampus exceed the threshold for production of a behavioral impairment. Objectives: In this study we seek to evaluate the effect of FK506 (tacrolimus) on spatial learning of rats subjected to 20-min global transient ischemia/reperfusion. Material and Methods: In experimental group1, FK506 (1mg/kg) was given intravenously (IV) 20 minutes before ischemia and in experimental group2 rats were treated with the same dose of tacrolimus (IV) at the beginning of reperfusion. Morris water maze tests were performed 1 week after ischemia for 4 days. Brain tissue proceeded to TUNEL staining. Results: Our data showed; 1) No statistically significant differences were seen between the experimental group1 and the control (intact) group thus, this suggests that treatment of ischemia with tacrolimus can improve spatial learning and memory. 2) Tacrolimus treatment ameliorated the increase of TUNEL–positive cells induced by cerebral ischemia indicating the neuro-protective properties of FK506. Conclusions: These results suggest that tacrolimus may reduce cognitive impairment and may be a good candidate for treatment of ischemic brain damage. Keywords: Neuroprotective Agents; Spatial Memory Disorders; Maze